Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HK.27.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.27.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HV.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HV.1.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HV.1.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HV.1.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HV.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.1.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.1.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.1.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.1.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.8.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.8.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.8.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.8.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.8.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.8.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.8.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.56EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.56ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.56ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.56EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.56EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.56ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.56ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.2.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.13ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.2.13ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.2.13EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.2.13EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KP.2.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used